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The molecular chaperone Hsp90 regulates the activity and stability of a set of client proteins. Despite prog-
ress in understanding its mechanism, the interaction of Hsp90 with clients has remained enigmatic. Now, in
a recent issue of Molecular Cell, Street and coworkers present results that integrate the client in the Hsp90
chaperone cycle.Hsp90 is a molecular chaperone found in
the cytosol of eubacteria and eukaryotes.
Unlike other promiscuous molecular
chaperones, it seems to interact with
a more defined set of client proteins that
include many regulatory proteins. During
its ATPase cycle, the Hsp90 dimer
undergoes large conformational changes
from an open to a closed conformation.
These changes are thought to be relevant
for the stabilization and activation of the
client proteins. Despite progress in recent
years on the structure of Hsp90, its
conformational regulation, the function
of cochaperones, and the growing lists
of bona fide client proteins, little is known
about how Hsp90 interacts with its
clients. In a recent issue of Molecular
Cell, Street et al. (2011) describe a tech-
nical tour de force to unveil the secrets
of this interaction. They show that
binding of a model client induces
a partially closed conformation of Hsp90
and at the same time enhances the
Hsp90 ATPase activity.
Hsp90, in its eukaryotic rendering, is one
of the most complex chaperone machin-
eries known, as it functions together with
a large set of cochaperones. In contrast
to eukaryotic Hsp90, bacterial Hsp90
(called HtpG in E. coli) seems to be a solo
player: none of these cochaperones has
been identified, yet prokaryotic Hsp90 is
highly homologous in structure to its eu-
karyotic counterpart, suggesting that the
basic mechanism is conserved (Buchner,
2010). Hsp90 proteins are homodimers,
with protomers consisting of three
domains each. The N-terminal domains
bind ATP and, together with parts of the
middle domains, form the split-ATPase
site. The C-terminal domains mediate thedimerization of Hsp90. During the ATP-
induced conformational cycle, the N-
terminal domains dimerize and associate
with themiddle domains. These rearrange-
ments are rate-limiting for the slowATPase
reaction, which is in the range of one ATP
hydrolysis per minute. In eukaryotes, there
are a growing number of proteins that
depend on these Hsp90 conformational
gymnastics to access or maintain their
active state. These include many protein
kinases and a number of transcription
factors, such as most steroid hormone
receptors, p53, and proteins as diverse as
viral reverse transcriptases and viral
coat proteins (see http://www.picard.ch/
downloads/Hsp90interactors.pdf). Again,
in contrast to its eukaryotic counterpart,
prokaryotic Hsp90 has only a few known
authentic clients, such as proteins from
phycobilisomes (Sato et al., 2010) and the
ribosomal protein L2 (Motojima-Miyazaki
et al., 2010).
Few studies to date have embarked on
the structural analysis of the interaction of
Hsp90 with client proteins. Experimen-
tally, this is a challenging problem, as
many of the authentic or model chap-
erone client proteins are unstable and
aggregation-prone. This severely limits
the accessibility of biophysical methods.
To overcome these hurdles, the Agard
laboratory decided to tackle this question
by using a well-behaved and well-studied
model client protein, a fragment of
staphylococcal nuclease (SN) that is
known to be largely unfolded in solution
and soluble even at high concentrations,
making it amenable to rigorous analysis
(Shortle, 2002). Addition of SN to E. coli
Hsp90 led to the formation of a specific
complex with low micromolar affinity andStructure 19, April 13, 2011a stoichiometry of one client per Hsp90
dimer.
This chaperone-client complex put the
authors in the unique position to apply
sophisticated techniques for addressing
key open questions. First, they asked
how the binding of a client protein affects
the conformational equilibrium of Hsp90.
SAXSexperiments revealed a compaction
of Hsp90 in the presence of SN, sugges-
tive of a transition from the open to
a more closed state of Hsp90 (Figure 1).
This effect was even more pronounced
in the presence of the nonhydrolysable
ATP-analog, AMP-PNP, which is known
to induce N-terminal dimerization leading
to the closed state of Hsp90. The prefer-
ence of SN for the closed state was
directly confirmed by a FRET system,
which allows monitoring of this transition
in Hsp90. Here, the addition of SN
resulted in the acceleration of the closing
kinetics. Furthermore, Hsp90 in the
closed state exhibited a higher affinity
for SN. Since this closing reaction is the
rate-limiting step in the Hsp90 ATPase
cycle, the authors also found an accelera-
tion of ATP hydrolysis consistent with
previous reports for human and E. coli
Hsp90 (McLaughlin et al., 2002; Moto-
jima-Miyazaki et al., 2010), supporting
the notion that this is an evolutionarily
conserved effect.
The authors also present new informa-
tion on the client-binding site of Hsp90.
Surprisingly, locations of the client-
binding sites are still an open question,
with published evidence for their localiza-
tion in each of the domains of Hsp90 (see
Buchner, 2010). Using SAXS experiments
together with Hsp90 variants, Street et al.
(2011) suggest that SN binds to theª2011 Elsevier Ltd All rights reserved 445
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Figure 1. The Conformational Cycle of Hsp90 in the Presence of a Client Protein
Hsp90 is a dimeric chaperone that can adopt several conformations (pink, open; green, more closed). It
binds to structurally labile client proteins (orange) via its middle domains. The client induces changes in
Hsp90 that help to overcome the slow conformational rearrangements prior to the ATP hydrolysis reaction.
The closing reaction of Hsp90 is initiated by ATP binding. Release of the folded client protein (orange
hexagon) may occur after the hydrolysis reaction. A structurally distinct Hsp90 complex containing the co-
chaperone Cdc37 and the client kinase Cdk4/6 (Vaughan et al., 2006) is shown on the left for comparison.
Structure
Previewsmiddle domain of Hsp90, which was also
implicated as the main interaction site for
an authentic client of bacterial Hsp90
(Sato et al., 2010). The resolution obtained
so far does not allow discrimination
between the symmetric or asymmetric
binding of the client to Hsp90. This is an
interesting and mechanistically important
question, as it was recently shown that
some cochaperones influence the Hsp90
dimer in an asymmetric manner (Retzlaff
et al., 2010; Li et al., 2011).
Finally, NMR spectroscopy was em-
ployed to gain insight into the interaction
site on SN. As mentioned, the larger part
of this SN variant is natively unfolded,
but it also contains a helical region. The
structure of the client protein did not
change strongly when bound to Hsp90.
Specifically, the signals of the helical
region became weaker in the Hsp90-
client protein complex, suggesting that
this region interacts with Hsp90. This
finding is consistent with the general
notion that Hsp90 interacts with folded,
native-like and potentially metastable
structures (Jakob et al., 1995), defining
the position of Hsp90 in the chaperone446 Structure 19, April 13, 2011 ª2011 Elsevnetwork of the cell downstream of other
chaperones such as Hsp70.
The study by the Agard lab on the anal-
ysis of an Hsp90-client complex is a huge
step forward in our understanding of how
this chaperone turns over its client
proteins. It shows that the client is a kinetic
accelerator of the initial conformational
changes in Hsp90, possibly facilitating
this transition by favorable interactions
with Hsp90. At least for eukaryotic
Hsp90, some clients seem to form very
stable complexes with Hsp90 in vivo,
which even survive coimmunoprecipita-
tion (Pratt and Toft, 1997). The affinity
determined here and previously in vitro
(McLaughlin et al., 2002) seems to be in
a different range. It will be exciting to
see to what extent the observed effects
can be transferred to high-affinity binding
endogenous client proteins in the future
and whether there is a unifying mecha-
nism for the interaction of Hsp90 with its
many structurally distinct client proteins.
For an Hsp90 kinase-cochaperone
complex, cryo-electron microscopy and
image processing suggested an interac-
tion of the native-like kinase with the N-ier Ltd All rights reservedand M-domains of Hsp90 (Figure 1)
(Vaughan et al., 2006). It remains to be
seen how the differences in interaction
can be related to client-specific effects
and how the interaction surfaces in
Hsp90 may be differentially used.
In the future, it will also be important to
consider howHsp90affects theconforma-
tion of the client protein. Hsp90 had been
proposed to facilitate conformational
changes, which are energetically unfavor-
able but important for the activation of
client proteins. In the context of this study,
it seems that the client primes Hsp90 for
conformational changes in response to
nucleotide binding, and it is reasonable to
assume that these conformational
changes may in some cases also affect
the conformation of the client protein
(Figure 1). The results presented by Street
et al. (2011) are therefore an important step
forward in understanding the chaperone
mechanismofHsp90.Theyplace theclient
in theHsp90chaperoningcycleandset the
stage for further experiments to elucidate
the underlying mechanism.
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